Oesophageal cancer: Fund a clinical trial to find a more effective treatment
Last updated: 12/09/2012
What's this project about?
The number of people diagnosed with oesophageal (foodpipe) cancer has risen in Great Britain over the past 30 years. Each year, around 8,000 people are diagnosed with oesophageal cancer in the UK - that's over 150 people every week.
Oesophageal cancer remains one of the hardest cancers to treat, often because it is diagnosed late. Beating oesophageal cancer is one of Cancer Research UK's priorities and we hope that our groundbreaking work will help survival rates to dramatically improve.
Supporting this project
Nicola donatedIn all our thoughts. Nic... In all our thoughts. Nick and the SJP team in Westerham more
Derek donatedWe're proud to say that we ... We're proud to say that we loved John from the bottom of our hearts. John we were so lucky to be part of your life. Derek,Linda,Rebecca,Hannah,Phoebe and Dan. more
Let your friends and family know about this project to get them involvedShare this project
What's the science behind the project?
Professor David Ferry is Professor of Medical Oncology at New Cross Hospital in Wolverhampton. He is leading a large clinical trial to see if the drug gefitinib (Iressa) can improve survival rates in people who have oesophageal cancer that has returned after treatment/chemotherapy. This trial has now recruited.
Doctors often use chemotherapy to treat oesophageal cancer that has come back, but while some people respond well to this treatment, others may not. Professor Ferry wants to see if gefitinib may be a more effective way to treat the disease.
Gefitinib works by blocking signals that can help cancer cells grow. This treatment may have benefits such as fewer side effects, as it specifically targets cancer cells and leaves healthy cells unharmed. Professor Ferry hopes to find out if gefitinib will improve survival and the quality of life for people whose oesophageal cancer has returned.
The difference you can make
The number of people surviving oesophageal cancer for at least 10 years after being diagnosed has trebled in the last 40 years.
Although this is a great achievement, the survival rate still remains low - with only around 1 in 10 patients likely to survive their disease for ten years. We hope to raise £60,000 - the amount of money that it would cost to support a research team working on a project like Professor Ferry's.
With work like that of Professor Ferry we believe we can turn these statistics around and help more people beat oesophageal cancer than ever before. With your help we can make this belief a reality.
Donate now and you can help support: Oesophageal cancer: Fund a clinical trial to find a more effective treatment